Deficiency of vitamin D receptor in keratinocytes augments dermal fibrosis and inflammation in a mouse model of HOCl-induced scleroderma.

[1]  Duane D. Miller,et al.  17,20S(OH)2pD Can Prevent the Development of Skin Fibrosis in the Bleomycin-Induced Scleroderma Mouse Model , 2021, International journal of molecular sciences.

[2]  W. Boehncke,et al.  Dysfunctional Keratinocytes Increase Dermal Inflammation in Systemic Sclerosis: Results From Studies Using Tissue‐Engineered Scleroderma Epidermis , 2021, Arthritis & rheumatology.

[3]  Wei Li,et al.  CYP11A1-derived vitamin D3 products protect against UVB-induced inflammation and promote keratinocytes differentiation. , 2020, Free radical biology & medicine.

[4]  C. Chizzolini,et al.  Interplay Between Keratinocytes and Fibroblasts: A Systematic Review Providing a New Angle for Understanding Skin Fibrotic Disorders , 2020, Frontiers in Immunology.

[5]  J. Pi,et al.  Nrf2 in keratinocytes protects against skin fibrosis via regulating epidermal lesion and inflammatory response. , 2020, Biochemical pharmacology.

[6]  Meng Meng,et al.  The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis , 2019, Front. Immunol..

[7]  B. Korman.  Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis. , 2019, Translational research : the journal of laboratory and clinical medicine.

[8]  E. Aldieri,et al.  Vitamin D inhibits the epithelial-mesenchymal transition by a negative feedback regulation of TGF-β activity , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  Jie Du,et al.  Vitamin D/VDR signaling inhibits LPS-induced IFNγ and IL-1β in Oral epithelia by regulating hypoxia-inducible factor-1α signaling pathway , 2019, Cell Communication and Signaling.

[10]  Thai D. Nguyen,et al.  Vitamin D Receptor Is Required for Proliferation, Migration, and Differentiation of Epidermal Stem Cells and Progeny during Cutaneous Wound Repair. , 2018, The Journal of investigative dermatology.

[11]  Y. Allanore,et al.  Regulatory T Cells in Systemic Sclerosis , 2018, Front. Immunol..

[12]  Yuan Yuan,et al.  ‘Psoriasis 1’ reduces psoriasis-like skin inflammation by inhibiting the VDR-mediated nuclear NF-κB and STAT signaling pathways , 2018, Molecular medicine reports.

[13]  Shi-You Chen,et al.  Transforming growth factor-β signaling in systemic sclerosis , 2018, Journal of biomedical research.

[14]  E. Wang,et al.  Vitamin D and the Pathophysiology of Inflammatory Skin Diseases , 2018, Skin Pharmacology and Physiology.

[15]  D. Khanna,et al.  Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta , 2017, Rheumatology.

[16]  C. Denton,et al.  SYSTEMIC SCLEROSIS , 2008 .

[17]  Yunfeng Bai,et al.  Phospholipase Cε deficiency delays the early stage of cutaneous wound healing and attenuates scar formation in mice. , 2017, Biochemical and biophysical research communications.

[18]  G. Schett,et al.  Vitamin D receptor regulates TGF-β signalling in systemic sclerosis. , 2015, Annals of the rheumatic diseases.

[19]  R. Lafyatis.  Transforming growth factor β—at the centre of systemic sclerosis , 2014, Nature Reviews Rheumatology.

[20]  J. Pablos,et al.  Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma , 2014, Archives of Dermatological Research.

[21]  A. Bosserhoff,et al.  Increased KGF expression promotes fibroblast activation in a double paracrine manner resulting in cutaneous fibrosis. , 2013, The Journal of investigative dermatology.

[22]  Hilary F Luderer,et al.  Ligand-dependent actions of the vitamin D receptor are required for activation of TGF-β signaling during the inflammatory response to cutaneous injury. , 2013, Endocrinology.

[23]  R. Moots,et al.  Neutrophil-derived reactive oxygen species in SSc. , 2012, Rheumatology.

[24]  R. Ogawa,et al.  Fibroproliferative Disorders and Their Mechanobiology , 2012, Connective tissue research.

[25]  M. Blomberg Jensen.  Vitamin D metabolism, sex hormones, and male reproductive function. , 2012, Reproduction.

[26]  D. Bikle.  Vitamin D metabolism and function in the skin , 2011, Molecular and Cellular Endocrinology.

[27]  Y. Shoenfeld,et al.  Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. , 2011, Autoimmunity reviews.

[28]  D. Abraham,et al.  Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. , 2010, The Journal of investigative dermatology.

[29]  P. Elias,et al.  Differential regulation of epidermal function by VDR coactivators , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[30]  Thomas A. Mustoe, MD, FACS,et al.  Occlusion regulates epidermal cytokine production and inhibits scar formation , 2010, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[31]  B. Pasche,et al.  Transforming growth factor β as a therapeutic target in systemic sclerosis , 2009, Nature Reviews Rheumatology.

[32]  T. Wynn,et al.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.

[33]  J. Kong,et al.  Regulation of IL-1 Family Cytokines IL-1α, IL-1 Receptor Antagonist, and IL-18 by 1,25-Dihydroxyvitamin D3 in Primary Keratinocytes1 , 2006, The Journal of Immunology.

[34]  T. Krieg,et al.  Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. , 2004, The American journal of pathology.

[35]  Michael T Longaker,et al.  Differences in collagen production between normal and keloid-derived fibroblasts in serum-media co-culture with keloid-derived keratinocytes. , 2002, Journal of dermatological science.

[36]  B. Dijkmans,et al.  Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. , 2000, Journal of the American Academy of Dermatology.

[37]  H. Tobi,et al.  A comparison of bleomycin-induced damage in lymphocytes and primary oral fibroblasts and keratinocytes in 30 subjects. , 1999, Mutagenesis.

[38]  J. Korn,et al.  Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy , 1996, The Lancet.